Susquehanna International Group
GNMK

Susquehanna International Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Susquehanna International Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,200
Closed -$220K – 13709
2021
Q1 		$220K Buy
+9,200
New +$171K ﹤0.01% 11232
2020
Q4 		– Sell
-26,800
Closed -$381K – 12017
2020
Q3 		$381K Sell
26,800
-106,700
-80% -$1.63M ﹤0.01% 8236
2020
Q2 		$1.96M Buy
+133,500
New +$1.36M ﹤0.01% 4534
2017
Q1 		– Sell
-15,000
Closed -$184K – 10397
2016
Q4 		$184K Sell
15,000
-5,400
-26% -$64.1K ﹤0.01% 8710
2016
Q3 		$241K Buy
20,400
+9,200
+82% +$88.8K ﹤0.01% 7294
2016
Q2 		$97K Buy
+11,200
New +$76.8K ﹤0.01% 8039

Susquehanna International Group's GNMK Position: Q1 2021 in Review

Susquehanna International Group sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 14,213 shares — an estimated $264K sold.

Susquehanna International Group first reported a position in GNMK in Q4 2014 and held it in 10 quarters. The position peaked at $727K in Q4 2016. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Susquehanna International Group reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Susquehanna International Group sold 14,213 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $264K.
  • Susquehanna International Group first reported a position in GenMark Diagnostics, Inc in Q4 2014 and held it in 10 quarters.
  • Susquehanna International Group's GenMark Diagnostics, Inc position peaked at $727K in Q4 2016.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.